HealthQuill Drugs
Exposure to certain endocrine-disrupting chemicals, especially musk ambrette, may trigger early puberty in girls, a study by the National Institutes of Health finds.
Drugs Health Pharma

Endocrine-disrupting chemicals may trigger early puberty in girls

Exposure to certain endocrine-disrupting chemicals, especially musk ambrette, may trigger early puberty in girls, a study by the National Institutes of Health finds.

Read More
The Namibian government’s move to cull 83 elephants to feed its population to support its “drought relief” plan has invited the ire of conservationists
Climate Drugs Medical

Namibia’s plan to cull elephants to feed drought-hit citizens draws ire

The Namibian government’s move to cull 83 elephants to feed its population to support its “drought relief” plan has invited the ire of.

Read More
Novo Nordisk, one of the world’s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises in heart diseases, for up to 1.03 billion euros ($1.1 billion).
Drugs Health Medical

World’s first whole-eye and partial face transplant recipient is doing well

HQ Team September 10, 2024: Aaron James, 46, the first-ever person to undergo a combined whole-eye and partial face transplant, is doing well.

Read More
People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing Parkinson’s disease, a Beth Israel Deaconess Medical Center study finds.
Drugs Health Pharma

GI tract damage may increase the risk of Parkinson’s disease by 76% 

People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing.

Read More
Sudan’s civil war is a “nightmare” and the World Health Organization has called on the international community to broker peace and provide the necessary short and long-term aid for the largest internal displacement of people in the world today.
Drugs Health Pharma

Sudan’s civil war is a ‘nightmare,’ WHO calls for urgent global action, aid

Sudan’s civil war is a “nightmare” and the World Health Organization has called on the international community to broker peace and provide the.

Read More
EQT Private Capital Asia will acquire a controlling stake in GeBBS Healthcare Solutions, a provider of healthcare outsourcing solutions from ChrysCapital, according to a statement from EQT.
Drugs Health Pharma

EQT Private Capital Asia to acquire controlling stake in US-based GeBBS

EQT Private Capital Asia will acquire a controlling stake in GeBBS Healthcare Solutions, a provider of healthcare outsourcing solutions from ChrysCapital, according to.

Read More
Summit Therapeutics Inc.’s investigational drug ivonescimab helps lung cancer patients to cut the risk of progression or death from the disease by 48%, the latest results of the company's trials reveal.
Drugs Health Pharma

Summit’s lung cancer drug reduces risk of disease progression by 48%

Summit Therapeutics Inc.’s investigational drug ivonescimab helps lung cancer patients to cut the risk of progression or death from the disease by 48%,.

Read More
India suspects a young male to be infected with mpox after he travelled to a country currently in the grip of the disease, according to a government statement.
Drugs Health Pharma

Young Indian male suspected to have mpox disease, contact tracing on

India suspects a young male to be infected with mpox after he travelled to a country currently in the grip of the disease,.

Read More
Merck’s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by the FDA.
Drugs Health Pharma

GSK’s Nucala Phase III trial shows promise in treating chronic lung disease

September 6, 2024: UK pharmaceutical giant GSK (GSK.L) announced that its asthma medicine, Nucala (mepolizumab), has shown positive results in a late-stage clinical.

Read More
India's Dr. Reddy's Laboratories has divested "certain" non-core dermatology brands of the company to Eris Lifesciences for INR 2.7 billion.
Drugs Medical Pharma

Dr. Reddy’s Laboratories faces regulatory setback in China

HQ Team September 6, 2024: The National Medical Products Administration (NMPA) of China has suspended the import, sale, and use of Dr Reddy’s.

Read More